Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratio of about 5% at the age of 50 to 15% at 70 years. Even though this is a common condition, related to both age and secondary medical conditions like diabetes, hypertension, dyslipedemia, depression and cardiovascular disease, there were treatments conducted in the past by mostly andrologists, urologists and sex therapists. There has been a revolutionary introduction of oral drug therapy to treat erectile dysfunction and the enormous studies concerning erectile dysfunction has led to a paradigm shift in erectile dysfunction treatment.

According to study conducted by Canadian Institute of Health Research, there were about 4,000 Canadian men between the age 40 and 88 years, nearly half of them had erectile dysfunction. It was about approximately two times more usual in men with cardiovascular disease and four times more usual among men suffering with any kind of diabetes. Increase in the number of erectile dysfunction cases has led to an increase in the Cialis drugs, proportionally boost the erectile dysfunction market.

The global erectile dysfunction market was valued at US$ 4,129.5 million in 2015 and is expected to witness a CAGR of 0.2% during the forecast period (2016 – 2024).

With the significant increase in revenue of Erectile Dysfunction Market, over last decade, more than 31 chemical moiety have advanced into the therapeutic pipeline, out of which 90% of drugs/molecules are developed by companies and 10% of the molecules/drugs are developed by Medical Universities and Institutes. However, the increase in the molecules and drug in clinical trials, the global drug pipeline for erectile dysfunction is still insufficient to address the unmet needs of treatment in low income countries. One of the basic challenge for the mid-level pharmaceutical companies are their lack of regional presence across the globe. The global pharmaceutical companies are now involved in expansion of their erectile dysfunction product portfolio by merger and acquisition policies. For instance, in 2014, Endo Pharmaceutical Holdings Sale of American Medical Systems. In brief, some of the private equity firms are interested to buy American Medical Systems which is one of the leading manufacturer of products used to treat pelvic disorders of male and female, erectile dysfunction prostheses, and laser technology devices.

According to pharma industry news, in 2012, Viagra drugs dominated the erectile dysfunction market with an approximate market share of about 45% in terms of revenue. Though, the market value for Viagra has declined due to its patent expiry in European countries by 2013, however the other pharmaceutical companies has then shown a keen interest in developing the generic Viagra drug for erectile dysfunction treatment. In-spite the patent loss, US market maintained a continual growth and is expected to dominate the erectile dysfunction market by 2020. The other prominent drug after Viagra is Cialis which holds the second largest market share globally. At present the market for Cialis drug is growing exceptionally well, however there can be an expected decline of Cialis’s drug market share as the patent expiration is due in mid of 2017. Furthermore, one of the Bayer’s erectile dysfunction drug, Levitra/Staxyn is expected to lose its patent by 2018 and is thus expected to contribute to the declining market revenue for Erectile Dysfunction Market. However, as there about 50 drug molecules under clinical trials, among which few drugs are expected to launch by 2018 and 2019 owing to increase in Erectile Dysfunction Market proportionally.

Erectile dysfunction is a sexual disorder characterized by the failure of a male individual to develop and maintain an erection of the penis during coitus. A penile erection is the process affecting the blood flow and reserve in sponge-like bodies within the penis. This causes arterial dilation, trabecular smooth muscle relaxation, and activation of the corporeal veno-occlusive mechanism. According to a Massachusetts Male Aging Study (MMAS) conducted by the European Association in 2015, the incidence of erectile dysfunction is 52% in non-institutionalized men in the urban and rural areas of Boston. In a cohort study by the MMAS, it was observed that one in four men seeking medical help for treating erectile dysfunction is above 40 years of age, with nearly 50% diagnosed with severe erectile dysfunction.

Market Dynamics

North America and Asia Pacific are the largest markets for erectile dysfunction products, as these regions have the highest prevalence of erectile dysfunction. For instance in the year 2012, according to The Massachusetts study, approximately 19,372 new cases of erectile dysfunction in Massachusetts and more than 721,615 cases in the United States yearly. China has a prevalence percentage of about 42.3 in the year 2011. There are many studies conducted to develop medication and medical devices to treat erectile dysfunction. According to the National Institutes of Health, over 30 million men over 75 years of age suffer from erectile dysfunction in the U.S. The Multinational Survey on the Aging Male (MSAM) study conducted in the U.S. and in European countries such as France, Germany, Italy, Netherlands, Spain, and the U.K. arrived at an unexplained relationship between lower urinary tract symptoms and sexual dysfunction in over 12 thousand men in the age group of 50-80 years. Of the 83% of the male population that was surveyed, who claimed to be sexually-active all the time, overall prevalence of lower urinary tract symptoms was 90%, with an overall incidence of erectile dysfunction pegged at 50%, and 10% of patients reported a complete absence of erection. Moreover, the overall incidence of ejaculation disorders was 46%.

Market Taxonomy

This report segments the global erectile dysfunction market on the basis of product, end user and geography. On the basis of product, the market is categorized into Viagra, Cialis, Stendra/ Spedra, Levitra, Zydena, and Vitaros. On the basis of end user, the market is categorized into hospitals, laboratories, homecare diagnostics, research institutes, and others. For comprehensive understanding of market dynamics, the global erectile dysfunction market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global erectile dysfunction market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics

The global erectile dysfunction market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers for erectile dysfunction products, research and consulting firms, new entrants, and financial analysts

Various strategy matrices used in analyzing the erectile dysfunction market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Erectile Dysfunction Market, By Product:

Viagra (Sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (Udenafil)

Vitaros (Alprostadil Cream)

Global Erectile Dysfunction Market, By Geography:

North America

U.S.

U.S. Erectile Dysfunction Market, By Product:

Viagra (Sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (Udenafil)

Vitaros (Alprostadil Cream)

Canada

Canada Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Europe

U.K.

U.K. Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Germany

Germany Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Italy

Italy Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

France

France Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Spain

Spain Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream

Russia

Russia Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Rest of Europe

Rest of Europe Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Asia Pacific

China

China Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

India

India Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Japan

Japan Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

ASEAN

ASEAN Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Australia

Australia Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

South Korea

South Korea Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Rest of Asia Pacific

Rest of Asia Pacific Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Latin America

Brazil

Brazil Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Mexico

Mexico Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Rest of Latin America

Rest of Latin America Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Middle East

GCC

GCC Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Israel

Israel Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Rest of Middle East

Rest of Middle East Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Africa

North Africa

North Africa Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Central Africa

Central Africa Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

South Africa

South Africa Erectile Dysfunction Market, By Product:

Viagra (sildenafil citrate)

Cialis (Tadalafil)

Stendra/Spedra

Levitra/Staxyn

Zydena (udenafil)

Vitaros (Alprostadil Cream)

Company Profiles

Meda Pharmaceuticals, Inc *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Future Plans

Coloplast

Global Life Technologies

Reflexonic, LLC

Augusta Medical System

Boston Scientific Corporation

Vivus, Inc

“*” marked represents similar segmentation in other categories in the respective section.

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

Primary Research (Trade Surveys and Experts Interviews)

Desk Research

Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Coherent Market Insights desk research is based on a principle set of research techniques:

National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.

Trade association, National and international media and trade press.

Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.

Scientific journals, and other technical magazines and whitepapers.

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

Micro-economic indicators

Macro-economic indicators

Environmental indicators

Socio-political indicators

Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

It provides first-hand information on the market dynamics, outlook, and growth parameters.

Industry experts validates the estimates which helps the company to cement the on-going research study.